Xenon Pharmaceuticals Inc (XENE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $44.92
• Market Cap: $3.44B
• EPS: $-3.89
• 52-Week High: $46.60
• 52-Week Low: $26.74

Market Sentiment

Xenon Pharmaceuticals Inc currently has a Bullish sentiment score of 0.16.

About Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in Burnaby, Canada, dedicated to pioneering innovative therapies for neurological disorders. With a diverse and promising pipeline of drug candidates, the company utilizes cutting-edge technologies to address genetic and rare conditions, significantly enhancing patient care and treatment options. Xenon's unwavering commitment to scientific rigor and patient-centric outcomes underscores its strategic positio...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Xenon Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XENE pay dividends?

Xenon Pharmaceuticals Inc (XENE) does not currently pay a regular dividend.

What is XENE's market cap?

Xenon Pharmaceuticals Inc (XENE) has a market capitalization of $3.44B with a current stock price of $44.92.